Eosinophilic cellulitis seems to be a type 2 inflammatory disease, with preferential activation of the Janus kinase (JAK)1/JAK2-signal transducer and activator of transcription (STAT)5 pathways, according to research published ...
Jun 21, 2023
0
2
Pediatric patients with hidradenitis suppurativa (HS) have a higher prevalence of Crohn disease, according to a research letter published online June 14 in JAMA Dermatology.
Jun 15, 2023
0
99
Atopic dermatitis (AD) in adulthood is associated with an increased risk for venous thromboembolism (VTE), according to a study published online May 31 in JAMA Dermatology.
Jun 1, 2023
0
0
A mindfulness and self-compassion training intervention is effective for improving quality of life (QOL) among adults with atopic dermatitis, according to a study published online May 10 in JAMA Dermatology.
May 10, 2023
0
22
Most people have heard of osteoarthritis and rheumatoid arthritis. But for some, psoriatic arthritis is the new kid on the block. Here's what you need to know about psoriatic arthritis, including symptoms, types and treatments.
Apr 24, 2023
0
19
For patients with recalcitrant alopecia areata totalis or universalis, methotrexate combined with prednisone yields complete hair regrowth in about 31 percent of patients, according to a study published online March 8 in ...
Mar 15, 2023
0
5
Most patients have favorable reactions to having access to dermatology clinic notes, according to a research letter published online March 8 in JAMA Dermatology.
Mar 9, 2023
0
2
The burden of alopecia areata (AA) is considerable in the United States, with people of color, especially Asians, disproportionately affected, according to a study published online March 1 in JAMA Dermatology.
Mar 6, 2023
0
8
Patients with severe eczema who were treated with the drug dupilumab experienced a reduction in symptoms and improved quality of life, according to a meta-analysis of several clinical trials published in JAMA Dermatology.
Mar 2, 2023
0
94
High-dose oral vitamin D reduced skin inflammation and increased immunoprotection in patients with chemical-induced skin rashes, according to findings from a recent Northwestern Medicine clinical trial published in JCI Insight.
Feb 15, 2023
0
37
